![]() |
市場調查報告書
商品編碼
1886956
便攜式超音波設備市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察,以及2024-2032年預測Compact Ultrasound Equipment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
受全球慢性病發病率上升、人口老化、技術進步以及即時診斷技術廣泛應用等因素的推動,全球便攜式超音波設備市場持續快速成長。根據最新產業數據,預計2024年全球便攜式超音波設備市場規模將達26.5億美元,2025年將達29.7億美元。預計到2032年,該市場將進一步成長至64億美元,2025年至2032年的複合年增長率將達到11.6%。對高度便攜、精準、高效的成像設備日益增長的需求,是推動市場強勁成長的主要動力。
市場概覽
緊湊型超音波設備是傳統桌上型超音波系統的小型便攜式版本。其輕巧便攜的設計使其能夠在醫院、診所、門診機構和偏遠地區提供高品質的影像。它們能夠在護理點提供即時影像,從而推動了全球需求。預計到2024年,北美將佔市場主導地位,市佔率達35.84%,市場規模將達到9.5億美元,主要得益於先進的醫療基礎設施和慢性病的高發生率。
領先的公司——皇家飛利浦公司、富士膠片株式會社、佳能醫療系統株式會社、通用電氣醫療集團和柯尼卡美能達株式會社——正透過推出新產品、開發整合人工智慧的設備以及拓展新的臨床應用領域不斷進行創新。
市場驅動因素
推動該市場發展的關鍵因素是全球慢性疾病的增加,例如心血管疾病、腎臟病、癌症和代謝性疾病,這些疾病需要透過非侵入性影像進行頻繁監測。例如,美國國立衛生研究院 (NIH) 於 2024 年 9 月報告稱,截至 2023 年,美國將有超過 80.8 萬人患有終末期腎病。美國國家生物技術資訊中心 (NCBI) 也估計,2025 年美國將新增約 200 萬例癌症病例。此外,世界衛生組織 (WHO) 於 2025 年 2 月預測,60 歲及以上人口將從 2023 年的 11 億增加到 2030 年的 14 億,這將推動對診斷解決方案的需求。
超音波技術安全、經濟高效且易於操作,因此在急診醫學、心臟病學、婦科、腎臟病學、泌尿科和家庭醫療保健等領域廣泛應用。這種轉變正在推動全球對小型便攜式設備的需求不斷增長。
市場限制因子
產品召回、監管警告以及熟練超音波技師短缺在一定程度上阻礙了市場成長。頻繁的召回事件,例如飛利浦因發燒問題於2024年3月召回其5000系列緊湊型超音波設備(屬於二級召回),以及Spark公司在2021年召回其設備,正在影響消費者信心並阻礙其廣泛應用。此外,人才短缺也是一個挑戰。英國2024年臨床放射科醫師調查發現,臨床放射科醫師缺口達30%,預計2028年將達40%。
市場機會
治療性超音波應用(神經調控、傷口護理、標靶藥物傳遞、癌症治療等)的進步為市場擴張帶來了巨大的機會。例如,Insightec公司的Exablate 4000平台於2021年獲得巴西國家衛生監督局(ANVISA)的批准,該平台利用磁振造影引導聚焦超音波技術,對特發性震顫和帕金森氏症進行非侵入性治療。
合作關係也為成長指明了方向。一個值得注意的例子是Buck Baits LLC和Kuhl Beans Roasting Company於2025年達成的合作,這將增強供應鏈的穩定性,並展現影像生態系統內更廣泛的合作。
市場趨勢
推動市場成長的關鍵趨勢之一是將人工智慧 (AI) 整合到小型超音波系統中。 AI 演算法可以提高影像清晰度、實現測量自動化、提升即時解讀的準確性並降低對操作者的依賴性。 2025 年 3 月,飛利浦發布了 5500CV,這是一款支援 AI 的小型超音波系統,凸顯了業界向更智慧、更有效率的影像解決方案轉型的趨勢。
製造商也正在開發便攜式 3D 和 4D 成像系統,以擴展診斷功能。飛利浦在 2022 年北美放射學會 (RSNA) 上發布的 5000 系列可為心血管、婦產科和床邊應用提供先進的 3D 影像。
細分市場洞察
預計在邁瑞 Consona 系列等基於控制台的便攜式設備的推出推動下,嵌入式控制台細分市場將在 2024 年引領市場。由於市場對輕巧、現代、觸控系統的需求不斷增長,因此觸控螢幕市場預計將保持穩定成長。
依成像類型劃分,3D 成像市場佔主導地位,其中支援即時視覺化的 4D 成像市場迅速成長。
依應用領域劃分,放射科將在 2024 年佔最大佔有率,這得益於人工智慧設備的推出,例如 Wipro GE 於 2025 年 3 月推出的 Versana Premier R3。醫院診所仍然是主要終端用戶,這主要受住院率上升和超音波在慢性病診斷中應用日益廣泛推動。
北美市場領先,歐洲市場保持穩定成長,這得益於 2023 年佳能發布的 Aplio Flex 和 Aplio Go 系統等新產品。亞太地區是成長最快的地區,這主要受慢性病盛行率上升和對早期診斷日益重視的推動。由於策略性醫療保健措施和診斷技術的普及,拉丁美洲、中東和非洲地區的醫療保健事業正在蓬勃發展。
The global compact ultrasound equipment market continues to expand rapidly, supported by the rising global burden of chronic diseases, growing geriatric population, technological advancements, and the widespread adoption of point-of-care diagnostics. According to the latest industry data, the global compact ultrasound equipment market was valued at USD 2.65 billion in 2024, is projected to reach USD 2.97 billion in 2025, and further expand to USD 6.40 billion by 2032, registering an impressive CAGR of 11.6% between 2025 and 2032. The growing need for portable, accurate, and efficient imaging devices is shaping the market's strong upward trajectory.
Market Overview
Compact ultrasound machines are smaller, portable versions of traditional console ultrasound systems, offering high-quality imaging in a lightweight, mobile design suitable for hospitals, clinics, ambulatory care settings, and remote locations. Their ability to deliver real-time imaging at the point of care is driving global demand. In 2024, North America dominated the market with a 35.84% share, generating USD 0.95 billion, owing to its advanced healthcare infrastructure and high prevalence of chronic diseases.
Leading companies-including Koninklijke Philips N.V., FUJIFILM Corporation, CANON MEDICAL SYSTEMS CORPORATION, GE HealthCare, and Konica Minolta, Inc.-continue to innovate with new product launches, AI-integrated devices, and expansion into new clinical applications.
Market Drivers
A critical driver for the market is the increasing global prevalence of chronic illnesses, such as cardiovascular diseases, kidney disorders, cancers, and metabolic diseases-conditions that require frequent diagnostic monitoring using non-invasive imaging. For instance, the NIH reported in September 2024 that over 808,000 people in the U.S. were living with end-stage renal disease in 2023, while the NCBI estimated around 2.0 million new cancer diagnoses in the U.S. for 2025. Additionally, the WHO projected in February 2025 that the global population aged 60+ will rise from 1.1 billion in 2023 to 1.4 billion by 2030, increasing demand for diagnostic solutions.
As ultrasound is safe, cost-effective, and easy to use, its adoption is rising across emergency care, cardiology, gynecology, nephrology, urology, and home-based care environments. This shift supports the growing global preference for compact, mobile devices.
Market Restraints
Market growth is partially hindered by product recalls, regulatory warnings, and shortages of skilled ultrasound technicians. Frequent recalls-such as Philips' Class 2 recall in March 2024 for its 5000 Compact Series due to heating issues, and Sparq device recall in 2021-affect consumer trust and hinder adoption. Additionally, staffing shortages pose challenges: the U.K.'s 2024 Clinical Radiology workforce census reported a 30% shortage of clinical radiologists, projected to reach 40% by 2028.
Market Opportunities
Advancements in therapeutic ultrasound applications-including neuromodulation, wound healing, targeted drug delivery, and cancer treatment-are opening significant opportunities for market expansion. For example, Insightec's Exablate 4000 platform, approved by ANVISA in 2021, uses MR-guided focused ultrasound for non-invasive treatment of essential tremor and Parkinson's disease.
Partnerships also offer avenues for growth. A notable example is the 2025 partnership between Buck Baits LLC and Kuhl Beans Roasting Company, strengthening supply chain stability and showcasing increasing collaboration within the imaging ecosystem.
Market Trends
A major trend accelerating market growth is the integration of artificial intelligence into compact ultrasound systems. AI algorithms enhance image clarity, automate measurements, improve real-time interpretation, and reduce operator dependency. In March 2025, Philips launched its AI-enabled Compact Ultrasound 5500CV, highlighting industry momentum toward smarter, more efficient imaging solutions.
Manufacturers are also developing portable 3D and 4D imaging systems to expand diagnostic capabilities. Philips' 5000 Series, launched at RSNA 2022, delivers advanced 3D imaging for cardiovascular, OB/GYN, and point-of-care applications.
Segmental Insights
The built-in-console segment dominates due to increasing launch of console-based portable devices such as Mindray's Consona series in 2024. The touchscreen segment is expected to grow steadily due to rising demand for lightweight, modern, touch-operated systems.
The 3D imaging segment leads the imaging type category, followed by rapid growth in 4D imaging for real-time visualization.
Among applications, radiology accounted for the largest share in 2024, supported by AI-enabled device launches such as Wipro GE's Versana Premier R3 in March 2025. Hospitals & clinics remain the leading end-users, driven by rising admissions and increasing use of ultrasound for chronic disease diagnosis.
North America leads the market, while Europe shows steady growth supported by new product launches like Canon's Aplio Flex and Aplio Go systems in 2023. Asia Pacific is the fastest-growing region, driven by rising chronic disease prevalence and increasing focus on early diagnosis. Latin America and the Middle East & Africa are expanding due to strategic healthcare initiatives and growing access to diagnostics.
Conclusion
With the global market increasing from USD 2.65 billion in 2024 to USD 6.40 billion by 2032, compact ultrasound equipment is set for strong future growth. The industry's shift toward portability, AI integration, and preventive diagnostics will play a crucial role in shaping healthcare delivery worldwide.
Segmentation By Product Type
By Imaging Type
By Application
By End-user
By Region